Literature DB >> 12579394

Response to Shiga toxin 1 and 2 in a baboon model of hemolytic uremic syndrome.

Richard L Siegler1, Tom G Obrig, Theodore J Pysher, Vernon L Tesh, Nathaniel D Denkers, Fletcher B Taylor.   

Abstract

Post-diarrheal (D+) hemolytic uremic syndrome (HUS) is caused by Shiga-toxin (Stx)-producing Escherichia coli. There is epidemiological, cell culture, and mouse model evidence that Stx2-producing E. coli are more likely to cause HUS than strains that produce only Stx1, but this hypothesis has not been tested in a primate model of HUS. We have developed a baboon model of Stx-mediated HUS that was employed to compare the clinical, cytokine, and histological response to equal amounts of the two Shiga toxins. Animals given IV Stx2 developed progressive thrombocytopenia, hemolytic anemia, and azotemia, and urinary interleukin-6 levels rose significantly. Glomerular thrombotic microangiopathy was found at necropsy. Animals given Stx1 showed no cytokine response and no clinical, laboratory, or histological signs of HUS. Our findings from the primate model corroborate previous epidemiological, cell culture, and mouse model observations, and suggest that enteric infection with Stx2-producing E. coli is more likely to cause HUS than infection with organisms that produce only Stx1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12579394     DOI: 10.1007/s00467-002-1035-7

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  25 in total

1.  Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome.

Authors:  D Maroeska W M Te Loo; Victor W M VAN Hinsbergh; Lambertus P W J VAN DEN Heuvel; Leo A H Monnens
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

2.  Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum.

Authors:  K Sandvig; O Garred; K Prydz; J V Kozlov; S H Hansen; B van Deurs
Journal:  Nature       Date:  1992-08-06       Impact factor: 49.962

Review 3.  Interleukin-6.

Authors:  M Lotz
Journal:  Cancer Invest       Date:  1993       Impact factor: 2.176

4.  Properties of strains of Escherichia coli belonging to serogroup O157 with special reference to production of Vero cytotoxins VT1 and VT2.

Authors:  S M Scotland; G A Willshaw; H R Smith; B Rowe
Journal:  Epidemiol Infect       Date:  1987-12       Impact factor: 2.451

5.  Haemolytic uraemic syndromes in the British Isles, 1985-8: association with verocytotoxin producing Escherichia coli. Part 2: Microbiological aspects.

Authors:  H Kleanthous; H R Smith; S M Scotland; R J Gross; B Rowe; C M Taylor; D V Milford
Journal:  Arch Dis Child       Date:  1990-07       Impact factor: 3.791

6.  Specific interaction of Escherichia coli O157:H7-derived Shiga-like toxin II with human renal endothelial cells.

Authors:  C B Louise; T G Obrig
Journal:  J Infect Dis       Date:  1995-11       Impact factor: 5.226

7.  Infections with Escherichia coli O157:H7 in Washington State. The first year of statewide disease surveillance.

Authors:  S M Ostroff; J M Kobayashi; J H Lewis
Journal:  JAMA       Date:  1989-07-21       Impact factor: 56.272

8.  In vivo modulation of coagulation and fibrinolysis by recombinant glycosylated human interleukin-6 in baboons.

Authors:  J C Mestries; E K Kruithof; M P Gascon; F Herodin; D Agay; A Ythier
Journal:  Eur Cytokine Netw       Date:  1994 May-Jun       Impact factor: 2.737

9.  Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance.

Authors:  H Nakajima; N Kiyokawa; Y U Katagiri; T Taguchi; T Suzuki; T Sekino; K Mimori; T Ebata; M Saito; H Nakao; T Takeda; J Fujimoto
Journal:  J Biol Chem       Date:  2001-09-13       Impact factor: 5.157

10.  Elimination of interleukin 6 attenuates coagulation activation in experimental endotoxemia in chimpanzees.

Authors:  T van der Poll; M Levi; C E Hack; H ten Cate; S J van Deventer; A J Eerenberg; E R de Groot; J Jansen; H Gallati; H R Büller
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

View more
  71 in total

1.  Strong association between shiga toxin-producing Escherichia coli O157 and virulence genes stx2 and eae as possible explanation for predominance of serogroup O157 in patients with haemolytic uraemic syndrome.

Authors:  D Werber; A Fruth; U Buchholz; R Prager; M H Kramer; A Ammon; H Tschäpe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-11-12       Impact factor: 3.267

2.  Identification of amino acids critical for the cytotoxicity of Shiga toxin 1 and 2 in Saccharomyces cerevisiae.

Authors:  Rong Di; Eric Kyu; Varsha Shete; Hemalatha Saidasan; Peter C Kahn; Nilgun E Tumer
Journal:  Toxicon       Date:  2010-12-22       Impact factor: 3.033

3.  Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates.

Authors:  Jean Pierre Girardeau; Alessandra Dalmasso; Yolande Bertin; Christian Ducrot; Séverine Bord; Valérie Livrelli; Christine Vernozy-Rozand; Christine Martin
Journal:  J Clin Microbiol       Date:  2005-12       Impact factor: 5.948

4.  Shiga-toxigenic Escherichia coli-inoculated neonatal piglets develop kidney lesions that are comparable to those in humans with hemolytic-uremic syndrome.

Authors:  J F Pohlenz; K R Winter; E A Dean-Nystrom
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

5.  An orally applicable Shiga toxin neutralizer functions in the intestine to inhibit the intracellular transport of the toxin.

Authors:  Miho Watanabe-Takahashi; Toshio Sato; Taeko Dohi; Noriko Noguchi; Fumi Kano; Masayuki Murata; Takashi Hamabata; Yasuhiro Natori; Kiyotaka Nishikawa
Journal:  Infect Immun       Date:  2009-10-26       Impact factor: 3.441

6.  Analysis of the genome of the Escherichia coli O157:H7 2006 spinach-associated outbreak isolate indicates candidate genes that may enhance virulence.

Authors:  Bridget R Kulasekara; Michael Jacobs; Yang Zhou; Zaining Wu; Elizabeth Sims; Channakhone Saenphimmachak; Laurence Rohmer; Jennifer M Ritchie; Matthew Radey; Matthew McKevitt; Theodore Larson Freeman; Hillary Hayden; Eric Haugen; Will Gillett; Christine Fong; Jean Chang; Viktoriya Beskhlebnaya; Matthew K Waldor; Mansour Samadpour; Thomas S Whittam; Rajinder Kaul; Mitchell Brittnacher; Samuel I Miller
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 7.  Structure, biological functions and applications of the AB5 toxins.

Authors:  Travis Beddoe; Adrienne W Paton; Jérôme Le Nours; Jamie Rossjohn; James C Paton
Journal:  Trends Biochem Sci       Date:  2010-03-02       Impact factor: 13.807

8.  Association of nucleotide polymorphisms within the O-antigen gene cluster of Escherichia coli O26, O45, O103, O111, O121, and O145 with serogroups and genetic subtypes.

Authors:  Keri N Norman; Nancy A Strockbine; James L Bono
Journal:  Appl Environ Microbiol       Date:  2012-07-13       Impact factor: 4.792

9.  Association of Escherichia coli O157:H7 tir polymorphisms with human infection.

Authors:  James L Bono; James E Keen; Michael L Clawson; Lisa M Durso; Michael P Heaton; William W Laegreid
Journal:  BMC Infect Dis       Date:  2007-08-24       Impact factor: 3.090

10.  Coculture of Escherichia coli O157:H7 with a Nonpathogenic E. coli Strain Increases Toxin Production and Virulence in a Germfree Mouse Model.

Authors:  Kakolie Goswami; Chun Chen; Lingzi Xiaoli; Kathryn A Eaton; Edward G Dudley
Journal:  Infect Immun       Date:  2015-08-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.